Skip to main content

Day: May 19, 2020

URBN Reports Preliminary Q1 Results

PHILADELPHIA, May 19, 2020 (GLOBE NEWSWIRE) — Urban Outfitters, Inc. (NASDAQ:URBN), a leading lifestyle products and services company which operates a portfolio of global consumer brands comprised of Anthropologie, BHLDN, Free People, Terrain, Urban Outfitters and Nuuly brands and the Menus & Venues division, today announced a preliminary net loss of $138 million and preliminary loss per diluted share of $1.41 for the three months ended April 30, 2020.The impact of the coronavirus pandemic (COVID-19) on the Company’s business has resulted in the need to perform impairment assessments of the Company’s long-lived assets. These preliminary financial results include a provisional impairment expense and the corresponding tax effects, all of which are currently being evaluated. While these items are non-cash in nature, a potential...

Continue reading

Xcel Brands, Inc. Announces First Quarter 2020 Results

•  First Quarter Total Revenues of $9.5 Million, •  GAAP Net Loss of $0.8 million, Diluted EPS of ($0.04) and  •  non-GAAP Diluted EPS of $0.00, Adjusted EBITDA of $0.6 millionNEW YORK, May 19, 2020 (GLOBE NEWSWIRE) — Xcel Brands, Inc. (NASDAQ: XELB) (“Xcel” or the “Company”), a media and consumer products company, today announced its financial results for the first quarter ended March 31, 2020.  Robert W. D’Loren, Chairman and Chief Executive Officer of Xcel commented, “We are pleased with the growth in our wholesale and e-commerce channels. Although our bottom-line results are down from last year’s first quarter, we are pleased with our results in light of the events associated with the COVID-19 pandemic. We remain vigilant over expense reductions and cash conservation so that we may emerge from this event stronger than...

Continue reading

Kornit Digital Reports First Quarter 2020 Results

First quarter revenue of $26.2 million, net of non-cash warrants impact of $0.6 millionFirst quarter 2020 GAAP operating loss of $13.0 million; Non-GAAP operating loss of $10.5 million, including $0.6 million attributed to the non-cash impact of warrantsFirst quarter 2020 performance reflects immediate short-term impact of COVID-19High confidence in delivering year-over-year growth for the second half of 2020ROSH-HA’AYIN, Israel, May 19, 2020 (GLOBE NEWSWIRE) — Kornit Digital Ltd. (NASDAQ: KRNT), a leading provider of digital printing solutions for the global textile industry, today reported results for the first quarter ended March 31, 2020.“While our first quarter 2020 results were significantly impacted by efforts to contain COVID-19, we are very encouraged by the global reopening of the economy and see a clear path to...

Continue reading

Performant Financial Corporation Announces Financial Results for First Quarter 2020

LIVERMORE, Calif., May 19, 2020 (GLOBE NEWSWIRE) — Performant Financial Corporation (Nasdaq: PFMT), (the “Company”), a leading provider of technology-enabled recovery and related analytics services in the United States, today reported the following financial results for its first quarter ended March 31, 2020: First Quarter Financial HighlightsTotal revenues of $45.9 million, compared to revenues of $34.9 million in the prior year periodNet loss of approximately $12.5 million, or $(0.23) per diluted share, compared to a net loss of $8.5 million, or $(0.16) per diluted share, in the prior year period. Included in the net loss was a non-cash impairment to goodwill of $19.0 millionAdjusted net income, excluding the non-cash goodwill charge was $2.1 million, or $0.04 per diluted share, compared to an adjusted net loss of...

Continue reading

IntriCon Acquires Emerald Medical Services

Synergistic joint development and manufacturing capability expands market opportunity in surgical navigationProvides immediate access to technology platform serving new high growth medical end-markets with complex interventional catheters  Accretive transaction delivers long-term revenue growth potential and diversifies customer baseARDEN HILLS, Minn., May 19, 2020 (GLOBE NEWSWIRE) — IntriCon Corporation (NASDAQ: IIN), a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices, today announced that it has completed the acquisition  of privately held Emerald Medical Services (EMS) Pte Ltd. The acquisition expands IntriCon’s medical coil and micro-miniature medical device engineering and manufacturing capabilities in surgical navigation and accelerates diversification into potential...

Continue reading

Covenant Transportation Group Announces First Quarter Financial and Operating Results

CHATTANOOGA, Tenn., May 19, 2020 (GLOBE NEWSWIRE) — Covenant Transportation Group, Inc.  (NASDAQ/GS: CVTI) (“CTG”) announced today financial and operating results for the first quarter ended March 31, 2020.Highlights for the quarter included the following:Total revenue of $213.6 million, a decrease of 2.6% compared with the first quarter of 2019.Freight revenue of $192.3 million (excludes revenue from fuel surcharges), a decrease of 1.8% compared with the first quarter of 2019.Operating income of $0.7 million and an operating ratio of 99.7%. Adjusted operating income(1) of $1.4 million and an adjusted operating ratio(1) of 99.3%. This compares with operating income of $5.4 million and an operating ratio of 97.5% and adjusted operating income(1) of $6.2 million and an adjusted operating ratio(1) of 96.9% in the first quarter of 2019.Net...

Continue reading

NuCana Reports First Quarter 2020 Financial Results and Provides Business Update

Clinical Studies Re-Opened to New Patient Enrollment Following Temporary Pause Due to COVID-19 PandemicNumerous Clinical Data Announcements Expected in 2020Cash and Cash Equivalents Expected to Fund Operations At Least into the Fourth Quarter of 2021EDINBURGH, United Kingdom, May 19, 2020 (GLOBE NEWSWIRE) — NuCana plc (NASDAQ: NCNA) announced financial results for the first quarter ended March 31, 2020 and provided an update on its broad clinical program with its transformative ProTide therapeutics.As of March 31, 2020, NuCana had cash and cash equivalents of £47.6 million compared to £52.0 million as of December 31, 2019. NuCana continues to advance its various clinical programs and reported a net loss of £4.0 million for the quarter ended March 31, 2020, as compared to £5.4 million for the quarter ended March 31, 2019. Basic and...

Continue reading

Cue Biopharma Reports First Quarter 2020 Results, Updates of CUE-101 Phase 1 Dose Escalation Study and Recent Business Highlights

CAMBRIDGE, Mass., May 19, 2020 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (NASDAQ: CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells within the body, provided a business update for the first quarter 2020.“We have successfully maintained momentum in meeting our business goals and clinical trial objectives for the first quarter and early second quarter of 2020, despite the rapid onset of COVID-19 and the many challenges it has presented,” said Daniel Passeri, chief executive officer of Cue Biopharma. “I am grateful for the dedication of the Cue Biopharma team during this pandemic as we continue to work together and safely execute on our mission of bringing novel therapies to patients with serious diseases.”According to Kerri-Ann Millar,...

Continue reading

Ascendis Pharma A/S Reports First Quarter 2020 Financial Results

– On track for filing U.S. Biologics License Application for TransCon hGH in second quarter, and advancing Marketing Authorisation Application in Europe to third quarter  –– Expanded commercial organization to support planned global launch of TransCon hGH –– Conference call today at 4:30 p.m. Eastern Time –COPENHAGEN, Denmark, May 19, 2020 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to address unmet medical needs, today announced financial results for the quarter ended March 31, 2020.“We continue to execute on our vision to build a leading biopharma company. In addition to remaining on track to achieve our corporate milestones for 2020, we continue to expand our organization to support the planned global launch of our first commercial product,...

Continue reading

Ag Growth International Inc. Announces Approval of All Resolutions at Annual and Special Meeting of Shareholders

WINNIPEG, Manitoba, May 19, 2020 (GLOBE NEWSWIRE) — Ag Growth International Inc. (TSX: AFN) (“AGI” or the “Company“) is pleased to announce the voting results from its annual and special meeting of shareholders held on May 19, 2020. A total of 10,155,224 common shares, representing approximately 54.31% of AGI’s outstanding shares, were represented in person or by proxy at the meeting.The following nominees were elected as directors for the ensuing year, with the specific voting results being as follows:In addition, all other resolutions presented at the meeting were approved by AGI’s shareholders, including the appointment of Ernst & Young LLP as auditors, the increase in shares issuable under our equity incentive award plan, the reconfirmation of our shareholder rights plan and the reduction...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.